Esophageal cancer (made up primarily of squamous and adenocarcinoma) is an understudied, yet aggressive form of cancer, ranking sixth in the world in terms of mortality 1 . While adenocarcinoma incidence has been steadily increasing in the Western world in the past decades, squamous cell carcinoma (ESCC) continues to be the major type of oesophageal cancer in Asia. Risk factors for ESCC include smoking, alcohol, drinking scalding hot beverages and poor nutrition 2 . For some of these risks, a geographical dependence can be observed; for example family history and high concentration of dietary nitrates are more prevalent risk factors in rural, highincidence areas of China, while esophageal cancer cases in urban, low incidence areas are more frequently associated with drinking tea at high temperature 3 , and hot-spots in the Kashmir Valley (India) relate to chewing nass 4 . How these factors differ in other parts of Asia, however, is less well understood.
populations, as well as germline variants in alcohol dehydrogenase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2) in Japanese populations have been associated with ESCC, the latter increasing the risk substantially when combined with smoking and alcohol consumption 5 .
With the advent of genome wide sequencing technologies a number of recent genomic studies, prevalently in Chinese populations [6] [7] [8] [9] , have started to map the somatic landscape of ESCC. These studies have highlighted tumour suppressors like TP53 and CDKN2A as common drivers, with the cell cycle (e.g. CCND1), RTK-MAPK-PI3K (e.g. PI3KCA), Notch pathways (e.g. NOTCH1), hedgehog signalling and epigenetic regulation also being frequent causes of mutation in this cancer.
Inactivating mutations in genes involved in chromatin remodelling (e.g. CREBBP), cell-cell communication (e.g. FAT1), or transcriptional regulation (e.g. ZNF750), among others, have also been noted. What is lacking is a connection between the causative agents and the mutational landscape that is observed in ESCC.
In the study by Sawada et al. of 144 Japanese patients, the authors investigated the relationship between the individual patient risk factors (alcohol, smoking and variants in specific inherited loci known to alter the metabolism of these carcinogens) and the acquired pattern of mutations in the cancer itself 10 . This includes analysis of mutations in specific genes (e.g. known cancer causing genes like TP53 and TGF beta) as well as elucidating "mutational signatures". In the past few years, large-scale analyses have revealed many mutational signatures, or characteristic imprints, across the genome of human cancers 11, 12 . These imprints possible to start attributing causality 13 .
In Japanese patients with ESCC 10 the authors identified three clusters of patients. Interestingly, these clusters were also shown to carry environmental and genetic associations: for example, heavy drinking in patients with the inherited ALDH2 risk allele were enriched in clusters 1 and 2, and somatic mutations in a potential tumour suppressor ZNF750 7 and PIK3CA signalling molecule mutations were also prevalent in the first cluster (containing a more prominent APOBEC signature).
The authors also undertook a concerted effort to compare the genomic profiles of ESCC in Japanese and Chinese populations (high and low incidence areas). They found that alcohol intake and smoking behaviour were more strongly associated with the incidence of this disease in Japan compared to China -also previously reported by e.g. Lin et al. 3 -but otherwise mutational spectra, driver genes (TP53, ZNF750, NOTCH1) and pathways seemed to be conserved across Japanese and In terms of what this study adds to our understanding, the mutational signature analysis performed here builds upon the work of Zhang et al 9 , who were the first to document the signature related to the APOBEC family of cytidine deaminases and the CpG signature in ESCC. Importantly, however, the study by Sawada et al shows that the various contributions of mutational processes in this cancer reveal subgroups of distinct aetiology, and these are informative of the different environmental influences and genetic predispositions in this disease ( Figure 1 ).
APOBEC mRNA deregulation has been linked to the APOBEC signature in a variety of cancers and was suggested to contribute to carcinogenesis 16 . Considering that cluster 1 displays a relatively high contribution of the APOBEC signature, as well as significantly more mutations in ZNF750, it will be interesting to see future studies into the molecular mechanism of this process in this ESCC subgroup.
Furthermore, the study highlights the importance of environmental risk factors to the development of ESCC and the fact that this can differ significantly even within territories of close geographical proximity. It is thus imperative to collect detailed exposure data in large-scale genomic cancer studies such as the International Cancer Genome Consortium to enable these inferences to be made.
From a therapeutic perspective, it is encouraging to observe that this diversity in risk factors is not reflected to the same extent at the genomic level, with driver genes and pathways being overall conserved among Chinese and Japanese populations.
Recent studies in other cancers have highlighted the potential of mutational signature-based stratification in the clinic. It has been suggested, for instance, that gastric tumours with homologous recombination (BRCA-signature related) defects might benefit from platinum/PARP inhibitors therapy 17 . Further research is needed to elucidate the applicability of this type of classification for early detection, prognosis or treatment of ESCC, especially since the mutational spectra and subgroup profiles seem to be maintained throughout Chinese and Japanese populations -and thus, would offer a promising strategy universally applicable in this cancer. 
